Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Collegium Pharma (COLL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 651,851
  • Shares Outstanding, K 32,560
  • Annual Sales, $ 1,710 K
  • Annual Income, $ -94,180 K
  • 36-Month Beta 0.42
  • Price/Sales 30.48
  • Price/Cash Flow N/A
  • Price/Book 6.15
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.98
  • Most Recent Earnings -0.45 on 11/08/17
  • Next Earnings Date 03/08/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.07 +17.28%
on 12/15/17
21.38 -6.36%
on 01/12/18
+2.11 (+11.78%)
since 12/12/17
3-Month
9.01 +122.20%
on 10/31/17
21.38 -6.36%
on 01/12/18
+8.18 (+69.09%)
since 10/12/17
52-Week
7.37 +171.64%
on 05/09/17
21.38 -6.36%
on 01/12/18
+4.02 (+25.13%)
since 01/12/17

Most Recent Stories

More News
Collegium Announces Closing of Agreement to License Rights to Commercialize Nucynta Franchise

-- Establishes Collegium as a leader in responsible pain management

COLL : 20.02 (-1.33%)
Collegium Pharma Shares Up 37.4% Since SmarTrend's Buy Recommendation (COLL)

SmarTrend identified an Uptrend for Collegium Pharma (NASDAQ:COLL) on November 10th, 2017 at $13.53. In approximately 2 months, Collegium Pharma has returned 37.40% as of today's recent price of $18.59....

COLL : 20.02 (-1.33%)
Shares of COLL Up 40.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Collegium Pharma (NASDAQ:COLL) on November 10th, 2017 at $13.53. In approximately 2 months, Collegium Pharma has returned 40.50% as of today's recent price of $19.01....

COLL : 20.02 (-1.33%)
Collegium Pharma Rises 3.53% on Heavy Volume: Watch For Potential Pullback

Collegium Pharma (NASDAQ:COLL) traded in a range yesterday that spanned from a low of $18.05 to a high of $19.27. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high...

COLL : 20.02 (-1.33%)
BioDelivery Sciences Reacquires ONSOLIS(R) from Collegium Pharmaceutical

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced that it has received the required 90-day notice from Collegium Pharmaceutical, Inc. regarding termination of the license and development...

COLL : 20.02 (-1.33%)
BDSI : 2.83 (+0.89%)
Collegium to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference

Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that management will be hosting investor meetings at the Guggenheim Securities 5 Annual Boston Healthcare Conference on Wednesday, December...

COLL : 20.02 (-1.33%)
Sage Therapeutics Soars: Stock Adds 7.1% in Session

Sage Therapeutics (SAGE) was a big mover last session, as the company saw its shares rise more than 7% on the day.

COLL : 20.02 (-1.33%)
SAGE : 175.86 (+0.72%)
Valeant (VRX) in Focus: Stock Moves 11.7% Higher

Valeant Pharmaceuticals International (VRX) was a big mover last session, as the company saw its shares rise nearly 12% on the day.

COLL : 20.02 (-1.33%)
VRX : 23.84 (+0.13%)
Free Research Reports on These Generic Drugs Stocks -- Ironwood Pharma, Neurocrine Biosciences, Collegium Pharma, and Mylan

In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on IRWD, NBIX, COLL, and MYL which is a click away at www.wallstequities.com/registration....

MYL : 46.90 (+0.41%)
COLL : 20.02 (-1.33%)
IRWD : 15.12 (+0.13%)
NBIX : 81.37 (+3.00%)
Detailed Research: Economic Perspectives on Electronic Arts, The Goodyear Tire & Rubber, Wendy's, Collegium Pharmaceutical, IAC/InterActiveCorp, and Endurance International Group -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Electronic Arts Inc. (NASDAQ:EA),...

WEN : 17.25 (+0.06%)
COLL : 20.02 (-1.33%)
EIGI : 8.80 (+1.73%)
IAC : 134.70 (+0.76%)
EA : 113.13 (+1.01%)
GT : 33.91 (+0.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

2nd Resistance Point 22.25
1st Resistance Point 21.13
Last Price 20.02
1st Support Level 19.15
2nd Support Level 18.29

See More

52-Week High 21.38
Last Price 20.02
Fibonacci 61.8% 16.03
Fibonacci 50% 14.38
Fibonacci 38.2% 12.72
52-Week Low 7.37

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.